Name

POC

Alternate names

PCV

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for POC

Name

Alternate Names

Belustine (nitrosourea)
CeeNu
Chloroethylcyclohexylnitrosourea
ICIG 1109
RB1509
WR-139017

Abbreviations

CCNU

Category

Chemotherapy

Subcategory

Alkylating agent

NSC Number

079037
79037

Primary Site

Brain tumors: primary or metastatic
Hodgkin lymphoma
Non-Hodgkin lymphoma

Histology

None

Remarks

Cell-cycle nonspecific antineoplastic agent;alkylating agent. FDA approved uses in brain tumor and Hodgkin's lymphoma.

Coding

This drug should be coded

Name

Alternate Names

Ibenzmethyzin Hydrochloride
Matulane
Methylhydrazine
N-Methylhydrazine
Natulan
Natulane
Procarbazine hydrochloride
Ro-4-6467
Ro4-6467/1

Abbreviations

IBZ
MIH
PCB
PCH
PCI
PCZ

Category

Chemotherapy

Subcategory

Nonclassic alkylating agent

NSC Number

077213
77213

Primary Site

Brain tumors adjuvant and/or advanced disease
Cutaneous T-cell lymphoma
Hodgkin lymphoma
Non-Hodgkin lymphoma

Histology

None

Remarks

An orally administered hydrazine derivative antineoplastic agent. FDA approved in stages III, IV Hodgkin's lymphoma.

Coding

This drug should be coded

Name

Alternate Names

Compound 37231
Leurocristine Sulfate
Oncovin
Vincasar
Vincasar PFS
Vincristine Sulfate
Vincrystine
Vinkristin

Abbreviations

LCR
VCR
VNCR

Category

Chemotherapy

Subcategory

Plant alkyloid--antimetabolite

NSC Number

067574
67574

Primary Site

None

Histology

None

Remarks

Antineoplastic; vinca plant alkaloid; antimetabolite. FDA approved uses in ALL, Hodgkin's lymphoma, non-Hodgkin's lymphoma, neuroblastoma, rhabomyosarcoma, and Wilm's tumor.

Coding

This drug should be coded
Glossary